ArticlePediatric blood & cancer2021

In vivo evaluation of the lysine-specific demethylase (KDM1A/LSD1) inhibitor SP-2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC).

Raushan T Kurmasheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.